当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析 - 现金流量表

益佰制药

(600594)

  

流通市值:33.66亿  总市值:33.66亿
流通股本:7.92亿   总股本:7.92亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,691,422,707.131,186,750,439.36518,157,625.12,498,962,508.56
  收到的税费返还1,051,843.961,051,843.96-75,315.1
  收到其他与经营活动有关的现金33,881,091.3329,329,226.7412,943,533.1257,907,028.04
  经营活动现金流入小计1,726,355,642.421,217,131,510.06531,101,158.222,556,944,851.7
  购买商品、接受劳务支付的现金344,011,463.21239,552,154.95121,999,778.04573,408,543.23
  支付给职工以及为职工支付的现金381,217,750.61267,479,787.94147,974,289.38569,805,756.03
  支付的各项税费127,384,781.888,282,027.6338,231,827.59193,818,082.34
  支付其他与经营活动有关的现金669,943,421.46451,264,713.86215,368,911.081,133,039,433.22
  经营活动现金流出小计1,522,557,417.081,046,578,684.38523,574,806.092,470,071,814.82
  经营活动产生的现金流量净额203,798,225.34170,552,825.687,526,352.1386,873,036.88
二、投资活动产生的现金流量:
  收回投资收到的现金---13,007.41
  取得投资收益收到的现金36,878.89---
  处置固定资产、无形资产和其他长期资产收回的现金净额10,76022,486.822,486.81,170,770
  收到的其他与投资活动有关的现金---11,303,104
  投资活动现金流入小计47,638.8922,486.822,486.812,486,881.41
  购建固定资产、无形资产和其他长期资产支付的现金20,850,212.5713,770,190.216,671,319.5696,321,108.52
  投资支付的现金---20,000,000
  支付其他与投资活动有关的现金2,164,525.67--2,601.48
  投资活动现金流出小计23,014,738.2413,770,190.216,671,319.56116,323,710
  投资活动产生的现金流量净额-22,967,099.35-13,747,703.41-6,648,832.76-103,836,828.59
三、筹资活动产生的现金流量:
  取得借款收到的现金427,999,999.5402,999,999.5222,999,999.5560,000,000
  筹资活动现金流入小计427,999,999.5402,999,999.5222,999,999.5560,000,000
  偿还债务支付的现金505,688,833.83363,260,000277,351,871.42596,249,335.14
  分配股利、利润或偿付利息支付的现金21,925,742.9314,856,616.077,642,247.5886,874,598.46
  支付其他与筹资活动有关的现金8,523,223.287,543,503.82,814,903.836,582,433.59
  筹资活动现金流出小计536,137,800.04385,660,119.87287,809,022.8719,706,367.19
  筹资活动产生的现金流量净额-108,137,800.5417,339,879.63-64,809,023.3-159,706,367.19
四、汇率变动对现金及现金等价物的影响-5,033.51-5,555.11-1,248.57-3,249.09
五、现金及现金等价物净增加额72,688,291.94174,139,446.79-63,932,752.5-176,673,407.99
  加:期初现金及现金等价物余额519,007,309.87519,007,309.87519,007,309.87695,680,717.86
  期末现金及现金等价物余额591,695,601.81693,146,756.66455,074,557.37519,007,309.87
补充资料:
  净利润--22,357,904.18--334,673,987.38
  资产减值准备-17,658,871.98-78,911,500.4
  固定资产和投资性房地产折旧-74,806,366.67-167,859,776.39
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-74,806,366.67-167,859,776.39
  无形资产摊销-8,087,814.12-16,035,982.71
  长期待摊费用摊销-11,225,552.98-34,337,546.15
  处置固定资产、无形资产和其他长期资产的损失--17,429.53--779,233.88
  固定资产报废损失-253,161.04-1,736,304.62
  财务费用-15,859,765.05-36,501,106.81
  投资损失-512,541.25--338,405.75
  递延所得税--9,500,590.5--37,462,444.42
  其中:递延所得税资产减少--8,240,227.33--34,761,710.32
    递延所得税负债增加--1,260,363.17--2,700,734.1
  存货的减少-20,622,506.6-41,748,007.2
  经营性应收项目的减少-109,333,174.15-184,277,936.34
  经营性应付项目的增加--60,766,093.23--105,378,453.42
  现金的期末余额-693,146,756.66-519,007,309.87
  减:现金的期初余额-519,007,309.87-695,680,717.86
  现金及现金等价物的净增加额-174,139,446.79--176,673,407.99
公告日期2025-10-302025-08-212025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑